{"transactions":[{"id":1374898,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":86294,"kind":"organization","name":"Marshman Fund Trust II","position":1,"cik":"0001821461","reported_name":"Marshman Fund Trust II","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-11-05T21:05:14.000Z","date":"2024-11-05","kind":"sale","planned":false,"acquired":false,"shares":600000,"price":30.3025,"value":18181500.0,"ownership":{"direct":true},"balance_after":6051120,"source":{"system":"sec-edgar","filing":"0001213900-24-094563","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000121390024094563/ownership.xml","form_type":"4"}},{"id":1374897,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":86294,"kind":"organization","name":"Marshman Fund Trust II","position":1,"cik":"0001821461","reported_name":"Marshman Fund Trust II","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-11-05T21:05:14.000Z","date":"2024-11-01","kind":"sale","planned":false,"acquired":false,"shares":4000000,"price":30.3025,"value":121210000.0,"ownership":{"direct":true},"balance_after":6651120,"source":{"system":"sec-edgar","filing":"0001213900-24-094563","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000121390024094563/ownership.xml","form_type":"4"}},{"id":3004764,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":86294,"kind":"organization","name":"Marshman Fund Trust II","position":1,"cik":"0001821461","reported_name":"Marshman Fund Trust II","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-10-16T21:00:08.000Z","date":"2020-08-21","kind":"purchase","acquired":true,"shares":339476,"price":24,"value":8147424.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On September 4, 2020, the reporting person filed a Form 4 amendment that incorrectly stated the number of shares of common stock beneficially owned after the reported transaction.  Following the transactions reported hereing, as of August 21, 2020, the reporting person owned 10,651,120 shares of Common Stock."}],"balance_after":10651120,"source":{"system":"sec-edgar","filing":"0000899243-20-028512","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000089924320028512/doc4.xml","form_type":"4"}},{"id":3037215,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":86294,"kind":"organization","name":"Marshman Fund Trust II","position":1,"cik":"0001821461","reported_name":"Marshman Fund Trust II","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2020-09-04T21:19:52.000Z","date":"2020-08-21","kind":"exercise","acquired":false,"shares":25000000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of preferred stock automatically converted on a 8.215-for-one basis into common stock upon the closing of the Issuer's initial public offering, with any fractional shares resulting from the conversion of the aggregate preferred stock held by the reporting person canceled in exchange for cash."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of preferred stock automatically converted on a 8.215-for-one basis into common stock upon the closing of the Issuer's initial public offering, with any fractional shares resulting from the conversion of the aggregate preferred stock held by the reporting person canceled in exchange for cash."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of preferred stock automatically converted on a 8.215-for-one basis into common stock upon the closing of the Issuer's initial public offering, with any fractional shares resulting from the conversion of the aggregate preferred stock held by the reporting person canceled in exchange for cash."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Includes 336,668.05 shares of common stock received upon the payment of an in-kind dividend on the Series A Preferred Stock on August 21, 2020."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3379881.68},"source":{"system":"sec-edgar","filing":"0000899243-20-024372","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000089924320024372/doc4a.xml","form_type":"4/A","original_submission_date":"2020-09-01"}},{"id":3037214,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":86294,"kind":"organization","name":"Marshman Fund Trust II","position":1,"cik":"0001821461","reported_name":"Marshman Fund Trust II","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-09-04T21:19:52.000Z","date":"2020-08-21","kind":"exercise","acquired":true,"shares":3379881,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of preferred stock automatically converted on a 8.215-for-one basis into common stock upon the closing of the Issuer's initial public offering, with any fractional shares resulting from the conversion of the aggregate preferred stock held by the reporting person canceled in exchange for cash."}],"balance_after":3379881,"source":{"system":"sec-edgar","filing":"0000899243-20-024372","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000089924320024372/doc4a.xml","form_type":"4/A","original_submission_date":"2020-09-01"}},{"id":3047302,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":86294,"kind":"organization","name":"Marshman Fund Trust II","position":1,"cik":"0001821461","reported_name":"Marshman Fund Trust II","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Preferred Stock","published_at":"2020-08-25T23:43:34.000Z","date":"2020-08-21","kind":"exercise","acquired":false,"shares":25983571,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of preffered stock automatically converted on a 8.215-for-1 basis into common stock upon the closing of the Issuer's initial public offering."},{"field":"shares","element":"transactionShares","label":"F2","text":"Includes 983,571 shares received upon the payment of an in-kind dividend on the Series A Preferred Stock on August 21, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of preffered stock automatically converted on a 8.215-for-1 basis into common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of preffered stock automatically converted on a 8.215-for-1 basis into common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Includes 983,571 shares received upon the payment of an in-kind dividend on the Series A Preferred Stock on August 21, 2020."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4026784},"source":{"system":"sec-edgar","filing":"0000899243-20-023396","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000089924320023396/doc4.xml","form_type":"4"}},{"id":3047301,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":86294,"kind":"organization","name":"Marshman Fund Trust II","position":1,"cik":"0001821461","reported_name":"Marshman Fund Trust II","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-08-25T23:43:34.000Z","date":"2020-08-21","kind":"exercise","acquired":true,"shares":4026784,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of preffered stock automatically converted on a 8.215-for-1 basis into common stock upon the closing of the Issuer's initial public offering."}],"balance_after":10958547,"source":{"system":"sec-edgar","filing":"0000899243-20-023396","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000089924320023396/doc4.xml","form_type":"4"}}]}